Evidence map›Paper›PMID 36112679›Full record

ArticleScience advances2022

A flexible electronic strain sensor for the real-time monitoring of tumor regression.

Alex Abramson, Carmel T Chan, Yasser Khan, Alana Mermin-Bunnell, Naoji Matsuhisa, Robyn Fong, Rohan Shad, William Hiesinger, Parag Mallick, Sanjiv Sam Gambhir and 1 more

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Implantable bioelectronic outlet.Science advances · 2026
    Article
  4. Liquid Metal-Enabled Soft Bioelectronics for Human Health Monitoring.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Wearable bioelectronics for cancer theranostics.Microsystems & nanoengineering · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alex AbramsonDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-4876-9751
Carmel T ChanDepartment of Radiology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-9553-0079
Yasser KhanDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-2290-0854
Alana Mermin-BunnellDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.
Naoji MatsuhisaDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-5978-2778
Robyn FongDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-7953-5109
Rohan ShadDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-0453-9041
William HiesingerDepartment of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
Parag MallickDepartment of Radiology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-0505-2032
Sanjiv Sam GambhirDepartment of Radiology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-2711-7554
Zhenan BaoDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-0972-1715

Funding

Biocompatible strain sensors for continuous monitoring of tumor progression during immunotherapy treatmentsF32EB029787 · NIBIB · STANFORD UNIVERSITY · PI ABRAMSON, ALEX · 2020 to 2021
$131k
NIBIB NIH HHS F32 EB029787
6 · The paper itself

Abstract

Assessing the efficacy of cancer therapeutics in mouse models is a critical step in treatment development. However, low-resolution measurement tools and small sample sizes make determining drug efficacy in vivo a difficult and time-intensive task. Here, we present a commercially scalable wearable electronic strain sensor that automates the in vivo testing of cancer therapeutics by continuously monitoring the micrometer-scale progression or regression of subcutaneously implanted tumors at the minute time scale. In two in vivo cancer mouse models, our sensor discerned differences in tumor volume dynamics between drug- and vehicle-treated tumors within 5 hours following therapy initiation. These short-term regression measurements were validated through histology, and caliper and bioluminescence measurements taken over weeklong treatment periods demonstrated the correlation with longer-term treatment response. We anticipate that real-time tumor regression datasets could help expedite and automate the process of screening cancer therapies in vivo.

Indexed as

CognitionElectronicsAnimalsDisease Models, AnimalLuminescent MeasurementsMice

Identifiers

PMID36112679
PMCPMC9481124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.